SCHEMBL6434824

SCHEMBL6434824

COC(=O)c1cc(C(=O)O)ccc1-c1cccc(N)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
GAA P10253 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
EGFR P00533 1/20 0.44
KDM4E B2RXH2 3/20 0.43
MCL1 Q07820 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
ATM Q13315 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6434822 0.92 MAPT (0.54) MAPTNPC1RAB9AGAAALDH1A1
SCHEMBL1569116 0.86 EGFR (0.57) MAPTGAAALDH1A1HPGDMEN1
SCHEMBL29441687 0.81 SLC6A3 (0.61) MAPTNPC1RAB9AGAAALDH1A1
SCHEMBL3920552 0.81 SLC6A3 (0.61) MAPTNPC1RAB9AGAAALDH1A1
SCHEMBL2726928 0.80 GAA (0.54) MAPTGAAALDH1A1HPGDMEN1
SCHEMBL6436941 0.80 TP53 (0.54) MAPTGAAALDH1A1MEN1KMT2A
SCHEMBL28789039 0.79 AKR1C3 (0.55) NPC1GAAALDH1A1MEN1KMT2A
SCHEMBL10058712 0.78 EGFR (0.63) MAPTRAB9AGAAALDH1A1HPGD
SCHEMBL4264020 0.78 MCL1 (0.47) MAPTGAAALDH1A1HPGDKDM4E
SCHEMBL28081743 0.78 MAPT (0.51) MAPTNPC1RAB9AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087943-B1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LTD (GB) 2005-08-17 EP disclosed
US-6251925-B1 AN AGONISTS FOR HUMAN BETA-3 ADRENOCEPTOR GLAXO WELLCOME INC. 2001-06-26 US disclosed
EP-1087943-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065877-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-12-23 WO disclosed